Immunological Characteristics of HIV-Infected Patients and Controls
. | n . | Lymphocytes (×106/L) . | In Serum (g/L) . | |||
---|---|---|---|---|---|---|
CD4+ . | CD8+ . | IgG . | IgA . | IgM . | ||
Blood donor controls | 10 | 810 (700-980) | 410 (340-510) | 10.0 (8.2-11.7) | 2.2 (1.8-2.7) | 1.1 (0.8-1.3) |
CDC group A/B | 12 | 290* (209-375) | 735† (655-915) | 18.2* (14.8-20.8) | 2.8 (2.0-3.4) | 1.7† (1.3-2.4) |
CDC group C | 12 | 20* (7-120) | 180 (107-695) | 18.6* (14.8-21.8) | 3.8* (2.7-5.6) | 1.1 (0.6-1.9) |
. | n . | Lymphocytes (×106/L) . | In Serum (g/L) . | |||
---|---|---|---|---|---|---|
CD4+ . | CD8+ . | IgG . | IgA . | IgM . | ||
Blood donor controls | 10 | 810 (700-980) | 410 (340-510) | 10.0 (8.2-11.7) | 2.2 (1.8-2.7) | 1.1 (0.8-1.3) |
CDC group A/B | 12 | 290* (209-375) | 735† (655-915) | 18.2* (14.8-20.8) | 2.8 (2.0-3.4) | 1.7† (1.3-2.4) |
CDC group C | 12 | 20* (7-120) | 180 (107-695) | 18.6* (14.8-21.8) | 3.8* (2.7-5.6) | 1.1 (0.6-1.9) |